首页 | 本学科首页   官方微博 | 高级检索  
     


Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer
Authors:Amit M. Algotar  M. Suzanne Stratton  Frederick. R. Ahmann  James Ranger‐Moore  Raymond B. Nagle  Patricia A. Thompson  Elizabeth Slate  Chiu H. Hsu  Bruce L. Dalkin  Puneet Sindhwani  Michael A. Holmes  John A. Tuckey  David. L. Graham  Howard L. Parnes  Steven P. Stratton
Affiliation:1. The University of Arizona Cancer Center, University of Arizona, Tucson, Arizona;2. Department of Medicine, College of Medicine, University of Arizona, Tucson, Arizona;3. Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona;4. Department of Pathology, College of Medicine, University of Arizona, Tucson, Arizona;5. Department of Anatomy and Cell Biology, College of Medicine, University of Arizona, Tucson, Arizona;6. Medical University of South Carolina, Charleston, South Carolina;7. Department of Urology, School of Medicine, University of Washington, Seattle, Washington;8. Department of Urology, University of Oklahoma, Oklahoma City, Oklahoma;9. Urology Clinic, Waikato Hospital, Hamilton, New Zealand;10. Auckland Hospital, Auckland, New Zealand;11. Carle Cancer Center, Urbana, Illinois;12. Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland
Abstract:
Keywords:prostate cancer  incidence  selenium supplementation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号